In this new minisode series, Mindy, Ryan, and Jen discuss a few recent newsworthy items healthcare leaders should be considering. The episode opens with a discussion of the Biden administration’s initial response to the COVID-10 pandemic (00:35), including the pledge to administer 100 million doses in his first 100 days, the invocation of the Defense Production Act, and the establishment of his COVID Response Taskforce. The conversation then moves to analyzing key healthcare hires in the Biden administration (06:47), including the nomination of Xavier Becerra for HHS Secretary, Vivek Murty for Surgeon General, Rochelle Walensky of the CDC, and Janet Woodcock of the FDA. Outside of the political landscape, vaccine development and distribution continues to make headlines (10:52), with more Americans expressing willingness to receive the vaccine, J&J releasing positive trial results, trials starting in juvenile populations, and Merck pulling their vaccine candidates from development. The episode concludes with a discussion of how Biden’s regulatory freeze memo (15:12), could directly counteract some lame-duck Trump decisions, particularly changes to HIPAA privacy rules, the FDA’s authority over medical devices, and prior authorization requirements.
Trending News EU – 16 June 2022
DEI & Clinical Trials – Driving Meaningful Change
Integrating Diversity, Equity, & Inclusion Throughout Clinical Trials
Pharmaceutical companies who choose not to build DEI into their business strategy are missing out on an opportunity to expand the reach of life-changing therapies while isolating large populations of potential consumers. In this insight, Vynamic covers how to integrate DEI within key steps of the clinical trials process to facilitate better outcomes for both patients and pharmaceutical companies alike.
- Life Sciences
Prioritizing Diversity, Equity, & Inclusion Across Research & Development
Vynamic helped a large, global life sciences organization identify multiple opportunities to improve their DEI strategy within their R&D department, including a roadmap that went beyond diversity in hiring and retention, and included DEI principles applied to the "business of life sciences" to not only help advance client priorities, but also raise the bar for the pharmaceutical industry.
- Life Sciences
Trending News – June 2nd, 2022
Activating Diversity, Equity, & Inclusion Through Employee Resource Councils
The leadership of a large home healthcare provider sought to operationalize their Diversity, Equity, & Inclusion (DEI) strategy across their organization. Read how Vynamic helped this organization activate Employee Resource Councils, successfully onboard a DEI leader, and introduce internal DEI branding.
Trending News – May 19, 2022
Innovations Across the Atlantic: What the US & UK Can Learn From Each Other When it Comes to Crisis Care
Unlocking Patient Access Through The Digital Front Door
Patient access is one of the most critical issues plaguing the current healthcare industry. A large, academic medical center and nationally-recognized integrated delivery network sought Vynamic's help to create innovative solutions to enable optimal patient access, opening the door to increasing health equity.
Want to learn more? Get in Touch!
Contact our team to learn more about how we can help your needs.